The carbapenem-based antibiotics market size is projected to reach US$ 5,346.62 million by 2028 from US$ 3,964.57 million in 2021; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028.
Generic versions of antibiotics are popular due to their availability and affordability. In addition, the expiry of patented carbapenem-based antibiotics has widen-up opportunities for generic drug manufacturers to enter the market with their cost-efficient drugs. The focus of generic drug producers is to increase the reach of these drugs. Moreover, the shortage of antibiotics to treat bacterial infections is also one of the prime factors driving the market’s growth. The increased production of generic carbapenem-based antibiotics has enlarged the drug availability in various low- and middle-income countries.
Generic versions of carbapenem drugs available in the market are ertapenem (Invanz), imipenem/cilastatin (Primaxin IM), doripenem (Doribax), and meropenem (Merrem). In addition, the growing number of generic players in the market is accelerating the production of generic drugs. Many Asian companies are engaged in developing active pharmaceutical ingredients (API), which are required to produce generic carbapenem-based antibiotics. In June 2021, JW Pharmaceutical, a South Korean company, announced it had completed production of its API for Ertapenem injection and shipped it to the US. The company plans to enter the global carbapenem antibiotic market in the coming years. It has also succeeded in developing its technology independently in Korea to produce Doripenem. Furthermore, the company plans to expand the sales of both API and finished drugs of Imipenem and Meropenem by exporting them to over 40 countries, including China and Japan. As a result, companies are accelerating generic drug production and driving the growth of the global carbapenem-based antibiotics market.
Based on type, the carbapenem-based antibiotics market is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest market share of the carbapenem based antibiotics market in 2021, and it is anticipated to register the highest CAGR in the carbapenem-based antibiotics market during the forecast period. The growing developments for carbapenem-based antibiotics are likely to drive the market growth in the future.
Based on indication, the carbapenem-based antibiotics market is segmented into bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the carbapenem-based antibiotics market in 2021 and is estimated to register the highest CAGR in the market during the forecast period.
By distribution channel, the carbapenem-based antibiotics market is segmented into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the carbapenem-based antibiotics market in 2021, and it is estimated to register the highest CAGR in the market during the forecast period.
Based on geography, the carbapenem-based antibiotics market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. North America dominates the global market share and is expected to hold its strong foothold in the coming years. The region is expected to witness a consistent growth in the future owing to factors such as increased adoption of carbapenem based antibiotics, high prescription rate of antibiotics, and advancements in research and development leading to the emergence and launch of new medicines. However, the market in Asia Pacific is expected to witness the fastest growth in the coming years. The carbapenem-based antibiotics market size in India and China is expected to grow rapidly owing to factors such as the large population, increasing focus of market players on developing novel vaccines and products at affordable prices, and high penetration of market players manufacturing generic drugs and exporting them across the world.
The World Health Organization (WHO), Food and Drug Administration (FDA), Saudi Clinical Trial Registry, National Institute for Health, Ministry of Health and Prevention, and Centers for Disease Control and Prevention (CDC) are among the primary and secondary sources referred to while preparing the report on the global carbapenem-based antibiotics market.
Reasons to Buy
Generic versions of antibiotics are popular due to their availability and affordability. In addition, the expiry of patented carbapenem-based antibiotics has widen-up opportunities for generic drug manufacturers to enter the market with their cost-efficient drugs. The focus of generic drug producers is to increase the reach of these drugs. Moreover, the shortage of antibiotics to treat bacterial infections is also one of the prime factors driving the market’s growth. The increased production of generic carbapenem-based antibiotics has enlarged the drug availability in various low- and middle-income countries.
Generic versions of carbapenem drugs available in the market are ertapenem (Invanz), imipenem/cilastatin (Primaxin IM), doripenem (Doribax), and meropenem (Merrem). In addition, the growing number of generic players in the market is accelerating the production of generic drugs. Many Asian companies are engaged in developing active pharmaceutical ingredients (API), which are required to produce generic carbapenem-based antibiotics. In June 2021, JW Pharmaceutical, a South Korean company, announced it had completed production of its API for Ertapenem injection and shipped it to the US. The company plans to enter the global carbapenem antibiotic market in the coming years. It has also succeeded in developing its technology independently in Korea to produce Doripenem. Furthermore, the company plans to expand the sales of both API and finished drugs of Imipenem and Meropenem by exporting them to over 40 countries, including China and Japan. As a result, companies are accelerating generic drug production and driving the growth of the global carbapenem-based antibiotics market.
Based on type, the carbapenem-based antibiotics market is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest market share of the carbapenem based antibiotics market in 2021, and it is anticipated to register the highest CAGR in the carbapenem-based antibiotics market during the forecast period. The growing developments for carbapenem-based antibiotics are likely to drive the market growth in the future.
Based on indication, the carbapenem-based antibiotics market is segmented into bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the carbapenem-based antibiotics market in 2021 and is estimated to register the highest CAGR in the market during the forecast period.
By distribution channel, the carbapenem-based antibiotics market is segmented into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the carbapenem-based antibiotics market in 2021, and it is estimated to register the highest CAGR in the market during the forecast period.
Based on geography, the carbapenem-based antibiotics market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. North America dominates the global market share and is expected to hold its strong foothold in the coming years. The region is expected to witness a consistent growth in the future owing to factors such as increased adoption of carbapenem based antibiotics, high prescription rate of antibiotics, and advancements in research and development leading to the emergence and launch of new medicines. However, the market in Asia Pacific is expected to witness the fastest growth in the coming years. The carbapenem-based antibiotics market size in India and China is expected to grow rapidly owing to factors such as the large population, increasing focus of market players on developing novel vaccines and products at affordable prices, and high penetration of market players manufacturing generic drugs and exporting them across the world.
The World Health Organization (WHO), Food and Drug Administration (FDA), Saudi Clinical Trial Registry, National Institute for Health, Ministry of Health and Prevention, and Centers for Disease Control and Prevention (CDC) are among the primary and secondary sources referred to while preparing the report on the global carbapenem-based antibiotics market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global carbapenem based antibiotics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global carbapenem based antibiotics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Carbapenem-based Antibiotics Market - By Type
1.3.2 Global Carbapenem-based Antibiotics Market - By Indication
1.3.3 Global Carbapenem-based Antibiotics Market - By Distribution Channel
1.3.4 Global Carbapenem-based Antibiotics Market - By Geography
2. Carbapenem-based Antibiotics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Carbapenem-based Antibiotics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America - PEST Analysis
4.3 Expert Opinions
5. Carbapenem-based Antibiotics Market - Key Market Dynamics
5.1 Drivers
5.1.1 Rising Prevalence of Gram-Negative Bacterial Infections
5.1.2 Increasing Production of Generic Drugs
5.2 Market Restraints
5.2.1 Tedious and Expensive Process of Antibiotic Development
5.3 Market Opportunities
5.3.1 Private and Public Partnerships
5.4 Future Trends
5.4.1 Strategic Advancement for New Antibiotic Identification
5.5 Impact Analysis
6. Carbapenem-based Antibiotics Market - Global Analysis
6.1 Global Carbapenem-based Antibiotics Market Revenue Forecast and Analysis
6.2 Global Carbapenem-based Antibiotics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Carbapenem-based Antibiotics Market Analysis - By Type
7.1 Overview
7.2 Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)
7.3 Meropenem
7.3.1 Overview
7.3.2 Meropenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Doripenem
7.4.1 Overview
7.4.2 Doripenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Imipenem
7.5.1 Overview
7.5.2 Imipenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Tebipenem
7.6.1 Overview
7.6.2 Tebipenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
8. Carbapenem-based Antibiotics Market - By Indication
8.1 Overview
8.2 Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)
8.3 Bacterial Meningitis
8.3.1 Overview
8.3.2 Bacterial Meningitis: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Acute Pelvic Infections
8.4.1 Overview
8.4.2 Acute Pelvic Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Respiratory Tract Infections
8.5.1 Overview
8.5.2 Respiratory Tract Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Intra-abdominal Infections
8.6.1 Overview
8.6.2 Intra-abdominal Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Urinary Tract Infections
8.7.1 Overview
8.7.2 Urinary Tract Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
9. Carbapenem-based Antibiotics Market - By Distribution Channel
9.1 Overview
9.2 Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)
9.3 Retail Pharmacies
9.3.1 Overview
9.3.2 Retail Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Online Pharmacies
9.4.1 Overview
9.4.2 Online Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Hospital Pharmacies
9.5.1 Overview
9.5.2 Hospital Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
10. Carbapenem-based Antibiotics Market - Regional Analysis
10.1 North America: Carbapenem-based Antibiotics Market
10.1.1 Overview
10.1.2 North America: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.1.3 North America: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.1.4 North America: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ Million)
10.1.5 North America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ Million)
10.1.6 North America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.1.1 US: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.1.2 US: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.1.6.1.3 US: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.1.6.1.4 US: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.1.6.2 Canada: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.2.1 Canada: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.2.2 Canada: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.1.6.2.3 Canada: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.1.6.2.4 Canada: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.1.6.3 Mexico: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.3.1 Mexico: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.3.2 Mexico: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.1.6.3.3 Mexico: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.1.6.3.4 Mexico: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.2 Europe: Carbapenem-based Antibiotics Market
10.2.1 Overview
10.2.2 Europe: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.3 Europe: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.2.4 Europe: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ Million)
10.2.5 Europe: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ Million)
10.2.6 Europe: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.2.6.1 UK: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.1.1 UK: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.1.2 UK: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.2.6.1.3 UK: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.2.6.1.4 UK: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.2.6.2 Germany: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.2.1 Germany: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.2.2 Germany: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.2.6.2.3 Germany: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.2.6.2.4 Germany: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.2.6.3 France: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.3.1 France: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.3.2 France: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.2.6.3.3 France: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.2.6.3.4 France: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.2.6.4 Italy: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.4.1 Italy: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.4.2 Italy: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.2.6.4.3 Italy: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.2.6.4.4 Italy: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.2.6.5 Spain: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.5.1 Spain: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.5.2 Spain: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.2.6.5.3 Spain: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.2.6.5.4 Spain: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.2.6.6 Rest of Europe: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.6.1 Rest of Europe: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.6.2 Rest of Europe: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.2.6.6.3 Rest of Europe: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.2.6.6.4 Rest of Europe: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.3 Asia Pacific: Carbapenem-based Antibiotics Market
10.3.1 Overview
10.3.2 Asia Pacific: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.3 Asia Pacific: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.3.4 Asia Pacific: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ Million)
10.3.5 Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ Million)
10.3.6 Asia Pacific: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.1.1 China: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.1.2 China: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.3.6.1.3 China: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.3.6.1.4 China: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.3.6.2 Japan: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.2.1 Japan: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.2.2 Japan: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.3.6.2.3 Japan: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.3.6.2.4 Japan: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.3.6.3 India: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.3.1 India: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.3.2 India: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.3.6.3.3 India: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.3.6.3.4 India: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.3.6.4 Australia: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.4.1 Australia: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.4.2 Australia: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.3.6.4.3 Australia: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.3.6.4.4 Australia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.3.6.5 South Korea: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.5.1 South Korea: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.5.2 South Korea: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.3.6.5.3 South Korea: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.3.6.5.4 South Korea: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.3.6.6 Rest of Asia Pacific: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.6.1 Rest of Asia Pacific: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.6.2 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.3.6.6.3 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.3.6.6.4 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.4 Middle East and Africa: Carbapenem-based Antibiotics Market
10.4.1 Overview
10.4.2 Middle East and Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.4.3 Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.4.4 Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ Million)
10.4.5 Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ Million)
10.4.6 Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.4.6.1 UAE: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.1.1 UAE: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.1.2 UAE: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.4.6.1.3 UAE: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.4.6.1.4 UAE: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.4.6.2 Saudi Arabia: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.2.1 Saudi Arabia: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.2.2 Saudi Arabia: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.4.6.2.3 Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.4.6.2.4 Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.4.6.3 South Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.3.1 South Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.3.2 South Africa: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.4.6.3.3 South Africa: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.4.6.3.4 South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.4.6.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.4.1 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.4.2 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.4.6.4.3 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.4.6.4.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.5 South and Central America: Carbapenem-based Antibiotics Market
10.5.1 Overview
10.5.2 South and Central America: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.5.3 South and Central America: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.5.4 South and Central America: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ Million)
10.5.5 South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ Million)
10.5.6 South and Central America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.1.1 Brazil: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.1.2 Brazil: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.5.6.1.3 Brazil: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.5.6.1.4 Brazil: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.5.6.2 Argentina: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.2.1 Argentina: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.2.2 Argentina: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.5.6.2.3 Argentina: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.5.6.2.4 Argentina: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
10.5.6.3 Rest of South and Central America: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.3.1 Rest of South and Central America: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.3.2 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Type, 2019-2028 (US$ ‘Million)
10.5.6.3.3 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Indication, 2019-2028 (US$ ‘Million)
10.5.6.3.4 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019-2028 (US$ ‘Million)
11. Impact of COVID-19 Pandemic on Global Carbapenem-based Antibiotics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Carbapenem-based Antibiotics Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Carbapenem-based Antibiotics Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 ACS Dobfar S.p.A
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Iterum Therapeutics plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 DAEWOONG PHARMACEUTICAL CO.,LTD
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Aurobindo Pharma Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Gland Pharma Limited
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck & Co., Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sumitomo Dainippon Pharma Co., Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Savior Lifetec
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Pfizer Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Spero Therapeutics
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Publisher
14.2 Glossary of TermsList of Tables
Table 1. North America: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 2. North America: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 4. US: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. US: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. US: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Canada: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Canada: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Canada: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. Mexico: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. Mexico: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. Mexico: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. Europe: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 14. Europe: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 17. UK: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 18. UK: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 19. Germany: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 20. Germany: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 21. Germany: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 22. France: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 23. France: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 24. France: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 25. Italy: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 26. Italy: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 27. Italy: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 28. Spain: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 29. Spain: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 30. Spain: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 31. Rest of Europe: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 32. Rest of Europe: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 33. Rest of Europe: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 34. Asia Pacific: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 35. Asia Pacific: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 37. China: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 38. China: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 39. China: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 40. Japan: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 41. Japan: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 42. Japan: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 43. India: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 44. India: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 45. India: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 46. Australia: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 47. Australia: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 48. Australia: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 49. South Korea: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 50. South Korea: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 51. South Korea: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 52. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 53. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 54. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 55. Middle East and Africa: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 56. Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 57. Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 58. UAE: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 59. UAE: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 60. UAE: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 61. Saudi Arabia: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 62. Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 63. Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 64. South Africa: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 65. South Africa: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 66. South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 67. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 68. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 69. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 70. South and Central America: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 71. South and Central America: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 72. South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 73. Brazil: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 74. Brazil: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 75. Brazil: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 76. Argentina: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 77. Argentina: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 78. Argentina: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 79. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Type - Revenue and Forecast to 2028 (US$ ‘Million)
Table 80. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 81. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ ‘Million)
Table 82. Organic Developments in the Carbapenem-based Antibiotics Market
Table 83. Inorganic Developments in the Carbapenem-based Antibiotics Market
Table 84. Glossary of Terms, Carbapenem-based Antibiotics Market
List of Figures
Figure 1. Carbapenem-based Antibiotics Market Segmentation
Figure 2. Carbapenem-based Antibiotics Segmentation, By Region
Figure 3. Global Carbapenem-based Antibiotics Market Overview
Figure 4. The Others Segment Held Largest Share of Type Segment in Carbapenem-based Antibiotics Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Carbapenem-based Antibiotics Market, By Geography (US$ Million)
Figure 7. Global Carbapenem-based Antibiotics Market- Leading Country Markets (US$ Million)
Figure 8. Global Carbapenem-based Antibiotics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Carbapenem-based Antibiotics Market Impact Analysis of Driver and Restraints
Figure 15. Global Carbapenem-based Antibiotics Market - Revenue Forecast and Analysis - 2021- 2028
Figure 16. Global Carbapenem-based Antibiotics Market - By Geography Forecast and Analysis - 2021- 2028.
Figure 17. Market Positioning of Key Players in Global Carbapenem-based Antibiotics Market
Figure 18. Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)
Figure 19. Meropenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Doripenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Imipenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Tebipenem: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)
Figure 25. Bacterial Meningitis: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Acute Pelvic Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Respiratory Tract Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Intra-abdominal Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Urinary Tract Infections: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)
Figure 32. Retail Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Online Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Hospital Pharmacies: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America: Carbapenem-based Antibiotics Market, by Key Country - Revenue (2021) (US$ ‘Million)
Figure 36. North America: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 37. North America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
Figure 38. US: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 39. Canada: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 40. Mexico: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 41. Europe: Carbapenem-based Antibiotics Market, by Key Country - Revenue (2021) (US$ ‘Million)
Figure 42. Europe: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 43. Europe: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
Figure 44. UK: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 45. Germany: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 46. France: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 47. Italy: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 48. Spain: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 49. Rest of Europe: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 50. Asia Pacific: Carbapenem-based Antibiotics Market, by Key Country - Revenue (2021) (US$ ‘Million)
Figure 51. Asia Pacific: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 52. Asia Pacific: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
Figure 53. China: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 54. Japan: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 55. India: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 56. Australia: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 57. South Korea: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 58. Rest of Asia Pacific: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 59. Middle East and Africa: Carbapenem-based Antibiotics Market, by Key Country - Revenue (2021) (US$ ‘Million)
Figure 60. Middle East and Africa: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 61. Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
Figure 62. UAE: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 63. Saudi Arabia: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 64. South Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 65. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 66. South and Central America: Carbapenem-based Antibiotics Market, by Key Country - Revenue (2021) (US$ ‘Million)
Figure 67. South and Central America: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 68. South and Central America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
Figure 69. Brazil: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 70. Argentina: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 71. Rest of South and Central America: Carbapenem-based Antibiotics Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 72. Impact Of COVID-19 Pandemic in North American Country Markets
Figure 73. Impact Of COVID-19 Pandemic in Europe Country Markets
Figure 74. Impact Of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 75. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 76. Impact Of COVID-19 Pandemic in South and Central America Country Markets
Figure 77. Growth Strategies in the Carbapenem-based Antibiotics Market (%)
Companies Mentioned
- Pfizer Inc.
- Savior Lifetec
- Sumitomo Dainippon Pharma Co., Ltd.
- Merck & Co., Inc.
- Gland Pharma Limited
- Aurobindo Pharma Ltd
- Daewoong Pharmaceutical Co.,Ltd,
- Iterum Therapeutics plc
- ACS Dobfar S.p.A
- Spero Therapeutics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | February 2022 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 3964.57 million |
| Forecasted Market Value ( USD | $ 5346.62 million |
| Compound Annual Growth Rate | 4.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
